A popular anticholesterol drug cuts older adults’ chances of developing dementia by more than half, according to a new review of 4.5 million medical records.
Earlier research offered a mixed picture of cholesterol-reducing statins and their ability to prevent Alzheimer’s disease and other dementias. Researchers at Boston University and the Veterans Administration (VA) in Washington, D.C.,
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.